SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote ()3/6/2000 8:59:00 PM
From: LT  Read Replies (1) of 1386
 
Pharmos Corp Year Losses 11c/Shr Vs 15c
Monday, March 6, 2000 07:31 P

Pharmos Corp. - Iselin, N.J.

Year Dec. 31:

1999 1998
Revenues $3,279,000 $1,540,000
Net income (4,618,000) (4,663,000)
Avg shrs (diluted) 42,725,157 37,277,186
Shr earns (diluted)

Net income (.11) (.15)
Figures in parentheses are losses.

Results for the quarter ended Dec. 31, 1999, weren't immediately available.

Pharmos Corp. (PARS, news, msgs) is a pharmaceutical company that develops products for ophthalmic and neurological uses.

Shares of Pharmos closed at 13 1/2, up 3 1/4 or 31.7%, on Nasdaq volume 16.4 million shares. Average daily volume is 2.1 million shares.

-Terrence L. Wade; Dow Jones Newswires; 201-938-5400


Quote for referenced ticker symbols: PARS

¸ 2000 Dow Jones & Company, Inc. All Rights Reserved
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext